Stock DNA
Specialty Chemicals
INR 7,450 Cr (Small Cap)
27.00
44
1.07%
-0.15
11.30%
2.66
Total Returns (Price + Dividend) 
Latest dividend: 22 per share ex-dividend date: Jul-31-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Galaxy Surfactants Ltd Quality Grade Downgrade: A Detailed Analysis of Business Fundamentals
Galaxy Surfactants Ltd has recently experienced a downgrade in its quality grade from good to average, reflecting shifts in its core business fundamentals. This article delves into the key financial metrics such as return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency to understand the factors behind this change and its implications for investors.
Read More
Galaxy Surfactants Ltd Valuation Shifts Signal Heightened Price Risk
Galaxy Surfactants Ltd has witnessed a marked change in its valuation parameters, transitioning from an expensive to a very expensive stock within the specialty chemicals sector. This shift, underscored by a price-to-earnings (P/E) ratio of 23.01 and a price-to-book value (P/BV) of 2.32, raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks.
Read More
Galaxy Surfactants Ltd Valuation Shifts Signal Heightened Price Risk
Galaxy Surfactants Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions amid a challenging specialty chemicals sector. Despite modest price gains, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now stand elevated relative to historical and peer averages, prompting a reassessment of its price attractiveness for investors.
Read More Announcements 
Board Meeting Intimation for Approving The Unaudited Financial Results Of The Company (Consolidated And Standalone) For The Quarter Ended June 30 2026.
06-Aug-2026 | Source : BSEGalaxy Surfactants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company (Consolidated and Standalone) for the quarter ended June 30 2026.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
22-Jul-2026 | Source : BSEPlease find attached intimation of Grant of Stock Options under Galaxy Surfactants Ltd- Performance Stock Option plan 2025 (PSOP-2025)
Announcement under Regulation 30 (LODR)-Newspaper Publication
20-Jul-2026 | Source : BSEPlease find attached newspaper advertisement of 40th AGM.
Corporate Actions 
13 Aug 2026
Galaxy Surfactants Ltd has declared 220% dividend, ex-date: 31 Jul 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
0.0271
Held by 6 Schemes (12.04%)
Held by 86 FIIs (3.82%)
Unnathan Shekhar (11.92%)
Axis Mutual Fund (4.38%)
8.37%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 27.63% vs 10.76% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -8.73% vs -9.47% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 27.84% vs 5.83% in Sep 2024
Growth in half year ended Sep 2025 is -11.22% vs 7.75% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 27.77% vs 7.45% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -10.52% vs 2.26% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 11.31% vs -15.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 1.14% vs -20.87% in Mar 2024